Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1209_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Preface
- •Contents
- •Contributors
- •Sub Heading
- •Outcomes
- •Study Limitation
- •Inconsistency
- •Directness
- •Precision
- •Publication Bias
- •Features Increasing Quality of Observational Studies
- •Large Magnitude of Effect
- •Introduction
- •Ask the Clinical Question
- •Find the Evidence
- •Appraise the Studies
- •The GRADE System
- •The Header
- •Dose Response Gradient
- •All Plausible Confounding Would Reduce the Demonstrated Effect or Increase it if No Effect Was Observed
- •Summary of Findings
- •Other Resources
- •References
- •Introduction
- •Search Strategy
- •Results
- •Resection Versus Observation for Giant Hemangiomas
- •Treatment of Giant Hemangiomas: Operative Approaches and Non-surgical Therapies
- •Recommendations
- •A Personal View of the Data
- •Recommendations
- •References
- •Introduction
- •Search Strategy
- •Results
- •Observation vs Surgical Treatment with Hepatectomy
- •Enucleation vs Hepatectomy
- •Minimal Invasive Approach
- •Recommendations
- •References
- •Introduction
- •Cavernous Hemangioma
- •Focal Nodular Hyperplasia
- •Hepatocellular Adenoma
- •Biliary Hamartoma
- •Conclusion
- •References
- •Introduction
- •Surgical Considerations
- •Congenital Cysts
- •Neoplastic Cysts
- •Traumatic Cysts
- •Infectious Cysts
- •Summary
- •References
- •Introduction
- •Search Strategy
- •Results
- •Non-operative Management
- •Angiography and Embolization
- •Outcomes
- •Surgical Strategies
- •Recommendations
- •A Personal View of the Data
- •Recommendations
- •References
- •Introduction
- •Search Strategy
- •Results
- •Resection of Hepatocellular Carcinoma
- •Transplantation for Hepatocellular Carcinoma
- •Expanding the Milan Criteria
- •Salvage Transplantation
- •Treatment Prior to Transplantation
- •Living Donor Liver Transplantation for HCC
- •Comparative Outcomes Between Resection and Transplantation for HCC
- •Recommendations
- •A Personal View of the Data
- •References
- •Introduction
- •Presentation
- •Diagnosis
- •Treatment
- •Alternative Therapies
- •Summary
- •References
- •Introduction
- •Search Strategy
- •Results
- •Clinical Relevance and Risk Factors of Hepatocellular Carcinoma
- •Screening Strategies
- •Serum Alpha-Feto Protein (AFP)
- •Ultrasonography (US) with or Without Serum AFP
- •Cross Sectional Imaging
- •Computed Tomography
- •Magnetic Resonance Imaging
- •References
- •Introduction
- •Search Strategy
- •Results
- •Short-Term Outcomes of Laparoscopic Liver Resection
- •Recommendations
- •A Personal View of the Data
- •Recommendations
- •Long-Term Outcomes in Laparoscopic Liver Resection
- •Hepatocellular Carcinoma
- •Metastatic Colorectal Cancer
- •Recommendations
- •A Personal View of the Data
- •Recommendations
- •References
- •Introduction
- •Search Strategy
- •Etiology of Liver Abscesses
- •Predicting Prognosis
- •Treatment Options
- •Antibiotic Therapy
- •Radiologic Intervention
- •Surgical Therapy
- •Liver Abscess After Liver Transplantation
- •Personal Experience
- •Summary
- •Recommendations
- •References
- •Introduction
- •Search Strategy
- •Results
- •Recommendations
- •The EASL-EORTC Clinical Practice Guidelines
- •Other Recommendations
- •A Personal View of the Data
- •Recommendations
- •References
- •Introduction
- •Search Strategy
- •Results
- •Additional Considerations
- •Recommendations Based on the Data
- •A Personal View of the Data
- •References
- •Introduction
- •Search Strategy
- •Results
- •The Child-Pugh Scoring System
- •The Model for End-Stage Liver Disease (MELD) Score
- •Computed Tomography (CT) Volumetry
- •Transient Elastography
- •The Indocyanine Green (ICG) Clearance Test
- •Recommendations Based on the Data
- •References
- •Introduction
- •Strategy Discussion
- •Results
- •Risk of Recurrence
- •Conclusion
- •Recommendations
- •References
- •Introduction
- •Liver Failure Following Liver Resection
- •Evaluation of the Degree of Chronic Liver Disease
- •Search Strategy
- •Liver Resections and the Childs-Turcotte-Pugh Score
- •Liver Resections and the Meld Score
- •Child-Turcotte-Pugh vs. MELD Score
- •A Personal View of the Data
- •Recommendations
- •References
- •Retrospective Studies
- •Prospective Studies
- •Summary and Recommendations
- •A Personal View of the Data
- •References
- •Introduction
- •Search Strategy
- •Results
- •Operative Time
- •Perioperative Mortality and Morbidity
- •Hospital Length of Stay
- •Long-Term Outcomes
- •Recommendations Based on the Data
- •Potential Exceptions to Recommendations
- •Utilization of CBDE and Future Directions for Training
- •References
- •Introduction
- •Search Strategy
- •Results of Single Incision Laparoscopic Cholecystectomy Compared with Standard Multi-port Laparoscopic Cholecystectomy
- •Peri-operative Morbidity and Mortality
- •Conversion Rates
- •Cost
- •Pain
- •Cosmesis, Patient Satisfaction, and Quality of Life Scores
- •Hernia Rates
- •Recommendations
- •A Personal View of the Data
- •References
- •Retrospective Review
- •Randomized Trials
- •Meta-analysis/Systematic Reviews
- •Introduction
- •Search Strategy
- •Results
- •Recurrent Cholangitis from Hepatolithiasis
- •Recurrent Cholangitis from Choledocholithiasis
- •Recurrent Cholangitis Following Biliary-Enteric Anastomosis for Benign Disease
- •Recommendations for Treatment of Recurrent Cholangitis
- •A Personal View of the Data
- •References
- •Introduction
- •Search Strategy
- •Results
- •PBDS After Complex Hepatobiliary Procedures
- •PBDS After Cholecystectomy
- •Surgical Repair
- •Percutaneous Therapy
- •Endoscopic Therapy
- •Studies with Multiple Treatment Techniques
- •Recommendations Based on the Data
- •A Personal View of the Data
- •References
- •Introduction
- •Search Strategy
- •Results
- •Long-Term Success Rate
- •Method of Repair
- •Mortality
- •Health-Related Quality of Life and Cost
- •A Personal View of the Data
- •Recommendation Based on the Data
- •References
- •Introduction
- •Search Strategy
- •Results
- •LCBDE Versus Postoperative ERCP
- •LCBDE Versus OCBCE
- •Recommendations Based on the Data
- •A Personal View of the Data
- •References
- •Introduction
- •Epidemiology
- •Clinical Presentation
- •Literature Search
- •Results
- •Treatment of Tis and T1a Tumors
- •Treatment of T1b Tumors
- •Treatment Options for Stage T2/T3
- •Common Bile Duct Resections
- •Port Site Resections
- •Adjuvant Chemotherapy
- •Expert View of the Data
- •References
- •Introduction
- •Search Strategy
- •Results
- •Enterolithotomy vs Enterolithotomy with Cholecystectomy and Cholecysto-Enteric Fistula Closure
- •Recurrent Gallstone Ileus
- •Minimally Invasive Techniques
- •Recommendations
- •A Personal View of the Data
- •Summary of Recommendations
- •References
- •Introduction
- •Search Strategy
- •Results
- •Studies Comparing Endoscopic and Surgical Intervention
- •Outcomes of Surgical Intervention
- •Outcomes of Endoscopic Intervention
- •Recommendations Based on the Data
- •Personal View of the Data
- •References
- •Introduction
- •Search Strategy
- •Results
- •Routine Versus Selective Cholangiography
- •Near Infrared Fluorescent Cholangiography
- •Recommendations
- •A Personal View of the Data
- •Recommendations
- •References
- •Introduction
- •Search Strategy
- •Endoscopic Therapy
- •Biliary Resection and Biliary Bypass
- •Risk of Malignancy
- •Recommendations
- •References
- •Introduction
- •Intrahepatic Cholangiocarcinoma (iCCA)
- •Perihilar Cholangiocarcinoma (pCCA)
- •Distal Cholangiocarcinoma
- •Primary Sclerosing Cholangitis
- •Novel Endoscopic Techniques
- •Personal View
- •Recommendations
- •References
- •Introduction
- •Search Strategy
- •Results
- •Transcatheter Arterial Embolization
- •Biliary Stenting
- •Recommendations
- •A Personal View of the Data
- •Recommendations
- •References
- •Introduction
- •Search Strategy
- •Results
- •Importance of a Negative Resection Margin for Prognosis After Curative-Intent Surgery for Perihilar Cholangiocarcinoma
- •Achieving a Negative Bile Duct Margin: Hepatectomy Versus Bile Duct Resection
- •Impact of Caudate Lobectomy in Hepatectomy for Hilar Cholangiocarcinoma
- •Preoperative Assessment of Perihilar Cholangiocarcinoma
- •Assessment of the Bile Duct Margin and Operative Outcome
- •Recommendations
- •A Personal View of the Data
- •Recommendations
- •References
- •Introduction
- •Search Strategy
- •Results
- •Clinical Relevance of PVT After Liver Transplantation
- •Treatment Strategies
- •Anticoagulation
- •Surgical Revascularization
- •Thrombolysis Without Mechanical Methods
- •Mechanical Methods with Thrombolysis
- •Mechanical Methods Without Thrombolysis
- •Recommendations
- •A Personal View of the Data
- •References
- •Introduction
- •Search Strategy
- •Results
- •First Line Therapy
- •Rescue Therapies
- •Balloon Tamponade
- •TIPS
- •Early TIPS
- •Complications of TIPS
- •Surgical Shunt
- •Recommendations
- •A Personal View of the Data
- •Recommendations
- •References
- •Introduction
- •Search
- •Results
- •Esophageal Varices
- •Ascites
- •Other Manifestations of Portal Hypertension
- •Non-esophageal Varices
- •Hepatic Hydrothorax
- •Hepatorenal Syndrome
- •Other
- •Recommendations
- •A Personal View of the Data
- •References
- •Introduction
- •Search Strategy
- •Results
- •Prevalence and Clinical Importance
- •Risk Factors
- •Detection and Evaluation
- •Natural History
- •Treatment Indications and Outcomes
- •Recommendations
- •Recommendations
- •References
- •Introduction
- •Search Strategy
- •Results
- •Patients with Interstitial, Edematous, or Mild Gallstone Pancreatitis
- •Patients with Severe or Necrotizing Pancreatitis
- •The Role for Endoscopic Sphincterotomy
- •Cost Implications
- •Recommendations
- •A Personal View of the Data
- •Recommendations
- •References
- •Introduction
- •Search Strategy
- •Results
- •Feeding in Severe Acute Pancreatitis and Pancreatic Necrosis-EN vs. PN
- •Route of Enteral Feeding in Acute Pancreatitis-NG vs. NJ
- •Type of TF
- •Timing of Feeding Initiation- Early vs. Late
- •Future Directions
- •Recommendations
- •A Personal View of the Data
- •References
- •Introduction
- •Search Strategy
- •Results
- •Surgical Versus Endoscopic Management
- •Laparoscopic Management
- •Endoscopic Management
- •Recommendations Based on the Data
- •A Personal View of the Data
- •References
- •Introduction
- •Search Strategy
- •Results
- •Early Studies: Prophylaxis and Decreased Infected Necrosis
- •Recent Randomized Trials: Prophylaxis Reconsidered
- •A Review of Disparate Results
- •Antimicrobial Resistance and Atypical Organisms
- •Evidence-Based Protocol for “On-Demand” Antibiotics
- •Summary and Recommendations
- •A Personal View of the Data
- •Recommendations
- •References
- •Introduction
- •Search Strategy
- •Management of Symptomatic Walled-Off Necrosis (WON)
- •Indication of Drainage
- •Which Modality to Choose
- •The Diminishing Role of Open Necrosectomy
- •Minimally Invasive Necrosectomy (MIN)
- •Laparoscopic Necrosectomy
- •Retroperitoneal Necrosectomy
- •Percutaneous Drainage
- •Endoscopic Necrosectomy
- •Step-Up Approach
- •Conclusion/Recommendations
- •A Personal View of the Data
- •References
- •Introduction
- •Search Strategy
- •Results
- •Open Procedure
- •Endoscopic Drainage
- •Laparoscopic Procedures
- •Recommendations Based on the Data
- •A Personal View of the Data
- •References
- •Introduction
- •Search Strategy
- •Results
- •Pain Relief
- •Morbidity and Mortality
- •Repeated Interventions, Hospitalizations, and Costs
- •Timing of Intervention
- •Recommendations
- •A Personal View of the Data
- •Recommendations
- •References
- •Introduction
- •Search Strategy
- •Results
- •Randomized Clinical Trials
- •Systematic Reviews and Meta-analysis
- •Recommendations
- •A Personal View of the Data
- •Recommendations
- •References
- •Introduction
- •Search Strategy
- •Results
- •Patient Selection
- •Perioperative Morbidity and Mortality
- •Islet Function
- •Pain Relief/Narcotic Requirement
- •QOL/Durability
- •Cancer Risk
- •Expert Consensus
- •Recommendations Based on the Data
- •A Personal View of the Data

53
18. Danet IM, Semelka RC, Braga L, Armao D, Woosley JT. Giant hemangioma of the liver: MR
imaging characteristics in 24 patients. Magn Reson Imaging. 2003;21:95–101.
19. Cheng HC, Tsai SH, Chiang JH, Chang CY. Hyalinized liver hemangioma mimicking malig-
nant tumor at MR imaging. AJR Am J Roentgenol. 1995;165:1016–7.
20. Shamsi K, De Schepper A, Degryse H, Deckers F. Focal nodular hyperplasia of the liver: radio-
logic fi ndings. Abdom Imaging. 1993;18:32–8.
21. Mathieu D, Bruneton JN, Drouillard J, Pointreau CC, Vasile N. Hepatic adenomas and focal
nodular hyperplasia: dynamic CT study. Radiology. 1986;160:53–8.
22. Choi CS, Freeny PC. Triphasic helical CT of hepatic focal nodular hyperplasia: incidence of
atypical fi ndings. AJR Am J Roentgenol. 1998;170:391–5.
23. Carlson SK, Johnson CD, Bender CE, Welch TJ. CT of focal nodular hyperplasia of the liver.
AJR Am J Roentgenol. 2000;174:705–12.
24. Brancatelli G, Federle MP, Katyal S, Kapoor V. Hemodynamic characterization of focal
nodular hyperplasia using three-dimensional volume-rendered multidetector CT angiography.
AJR Am J Roentgenol. 2002;179:81–5.
25. Mortele KJ, Praet M, Van Vlierberghe H, Kunnen M, Ros PR. CT and MR imaging fi ndings in
focal nodular hyperplasia of the liver: radiologic-pathologic correlation. AJR Am J Roentgenol.
2000;175:687–92.
26. Procacci C, Fugazzola C, Cinquino M, et al. Contribution of CT to characterization of focal
nodular hyperplasia of the liver. Gastrointest Radiol. 1992;17:63–73.
27. Shen YH, Fan J, Wu ZQ, et al. Focal nodular hyperplasia of the liver in 86 patients. Hepatobiliary
Pancreat Dis Int. 2007;6:52–7.
28. Ferlicot S, Kobeiter H, Tran Van Nhieu J, et al. MRI of atypical focal nodular hyperplasia of
the liver: radiology-pathology correlation. AJR Am J Roentgenol. 2004;182:1227–31.
29. Vilgrain V, Flejou JF, Arrive L, et al. Focal nodular hyperplasia of the liver: MR imaging and
pathologic correlation in 37 patients. Radiology. 1992;184:699–703.
30. Rummeny E, Weissleder R, Sironi S, et al. Central scars in primary liver tumors: MR features,
specifi city, and pathologic correlation. Radiology. 1989;171:323–6.
31. Grazioli L, Morana G, Federle MP, et al. Focal nodular hyperplasia: morphologic and
functional information from MR imaging with gadobenate dimeglumine. Radiology.
2001;221:731–9.
32. Mahfouz AE, Hamm B, Taupitz M, Wolf KJ. Hypervascular liver lesions: differentiation of
focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR
imaging. Radiology. 1993;186:133–8.
33. Huppertz A, Haraida S, Kraus A, et al. Enhancement of focal liver lesions at gadoxetic
acid- enhanced MR imaging: correlation with histopathologic fi ndings and spiral CT – initial
observations. Radiology. 2005;234:468–78.
34. Grazioli L, Morana G, Kirchin MA, Schneider G. Accurate differentiation of focal nodular
hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging:
prospective study. Radiology. 2005;236:166–77.
35. Bieze M, van den Esschert JW, Nio CY, et al. Diagnostic accuracy of MRI in differentiating
hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional
value of gadoxetate disodium. AJR Am J Roentgenol. 2012;199:26–34.
36. Grazioli L, Bondioni MP, Haradome H, et al. Hepatocellular adenoma and focal nodular
hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis.
Radiology. 2012;262:520–9.
37. Welch TJ, Sheedy 2nd PF, Johnson CM, et al. Focal nodular hyperplasia and hepatic adenoma:
comparison of angiography, CT, US, and scintigraphy. Radiology. 1985;156:593–5.
38. Grazioli L, Federle MP, Ichikawa T, Balzano E, Nalesnik M, Madariaga J. Liver adenomatosis:
clinical, histopathologic, and imaging fi ndings in 15 patients. Radiology. 2000;216:395–402.
39. Ichikawa T, Federle MP, Grazioli L, Nalesnik M. Hepatocellular adenoma: multiphasic CT and
histopathologic fi ndings in 25 patients. Radiology. 2000;214:861–8.
4 Which Diagnostic Modality is best to Assess Benign Hepatic Tumors?

54
40. Grazioli L, Federle MP, Brancatelli G, Ichikawa T, Olivetti L, Blachar A. Hepatic adenomas:
imaging and pathologic fi ndings. Radiographics. 2001;21:877–92; discussion 892–874.
41. Hussain SM, van den Bos IC, Dwarkasing RS, Kuiper JW, den Hollander J. Hepatocellular
adenoma: fi ndings at state-of-the-art magnetic resonance imaging, ultrasound, computed
tomography and pathologic analysis. Eur Radiol. 2006;16:1873–86.
42. van Aalten SM, Thomeer MG, Terkivatan T, et al. Hepatocellular adenomas: correlation of MR
imaging fi ndings with pathologic subtype classifi cation. Radiology. 2011;261:172–81.
43. Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud
H. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular
pathological classifi cation. Hepatology. 2008;48:808–18.
44. Paulson EK, McClellan JS, Washington K, Spritzer CE, Meyers WC, Baker ME. Hepatic ade-
noma: MR characteristics and correlation with pathologic fi ndings. AJR Am J Roentgenol.
1994;163:113–6.
45. Bioulac-Sage P, Rebouissou S, Thomas C, et al. Hepatocellular adenoma subtype classifi cation
using molecular markers and immunohistochemistry. Hepatology. 2007;46:740–8.
46. Thomeer MG, Willemssen FE, Biermann KK, et al. MRI features of infl ammatory hepatocel-
lular adenomas on hepatocyte phase imaging with liver-specifi c contrast agents. J Magn Reson
Imaging. 2014;39:1259–64.
47. Zheng RQ, Zhang B, Kudo M, Onda H, Inoue T. Imaging fi ndings of biliary hamartomas.
World J Gastroenterol. 2005;11:6354–9.
48. Lev-Toaff AS, Bach AM, Wechsler RJ, Hilpert PL, Gatalica Z, Rubin R. The radiologic and
pathologic spectrum of biliary hamartomas. AJR Am J Roentgenol. 1995;165:309–13.
49. Sada PN, Ramakrishna B. Computed tomography of von Meyenburg complex simulating
micro-abscesses. Australas Radiol. 1994;38:225–6.
50. Eisenberg D, Hurwitz L, Yu AC. CT and sonography of multiple bile-duct hamartomas
simulating malignant liver disease (case report). AJR Am J Roentgenol. 1986;147:279–80.
51. Semelka RC, Hussain SM, Marcos HB, Woosley JT. Biliary hamartomas: solitary and multiple
lesions shown on current MR techniques including gadolinium enhancement. J Magn Reson
Imaging. 1999;10:196–201.
S. Thomas and A. Oto

55© Springer International Publishing Switzerland 2016
J.M. Millis, J.B. Matthews (eds.), Diffi cult Decisions in Hepatobiliary
and Pancreatic Surgery, Diffi cult Decisions in Surgery: An Evidence-Based
Approach, DOI 10.1007/978-3-319-27365-5_5
Chapter 5
Cystic Diseases of the Liver
John F. Renz
Abstract This manuscript provides a concise surgical review of cystic diseases of
the liver. Attention is paid to diagnosis, pre-surgical evaluation, surgical techniques,
including laparoscopy, and post-surgical care of the patient with cystic disease of
the liver.
Keywords Liver cyst • Liver surgery • Hepatobiliary surgery • Cystic disease of the
liver • Cystadenoma
Introduction
Cystic disease of the liver is a frequent indication for surgical consultation as
modern cross-sectional imaging identifi es some form of hepatic cystic disease in as
high as 18 % of studies [ 1 ]. A myriad of conditions manifest cystic disease of the
liver with an equally broad spectrum of prognoses; however, the overall management of cystic diseases within the liver is straightforward provided one adheres to
several guiding principles. Furthermore, the widespread application of laparoscopy
and intra-operative ultrasound has signifi cantly improved therapeutic options for
patients and surgeons.
Surgical Considerations
The approach to cystic diseases of the liver begins with recognition of four broad
classifi cations based upon etiology. These categories are: congenital, neoplastic,
traumatic, and infectious. Congenital cysts are, by far, the most prevalent and arise
from a defect in production of bile duct basement membrane resulting in cystic
J. F. Renz (*)
University of Chicago Medicine , 5841 S. Maryland,
Room J517 MC5027 , Chicago , IL 60637 , USA
e-mail:
jrenz@surgery.bsd.uchicago.edu

56
malformation of intrahepatic bile ducts [ 2 , 3 ]. These include simple cysts and adult
polycystic liver disease (APLD) [ 3 ]. Neoplastic cysts may be primary or metastatic.
Cystadenoma and cystadenocarcinoma may originate within the liver while cystadenocarcinomas from the ovary and pancreas often metastasize to the liver. Traumatic
cysts form secondary to liver injury such as disruption of an intrahepatic bile duct
or subcapsular hematoma. Infectious cysts include pyogenic liver abscess , hydatid
disease, and amoebic abscesses as well as extra-hepatic cysts secondary to retained
gallstones from a previous cholecystectomy [ 2 ]. Formulating a robust working
hypothesis as to the origin of the cyst is essential to anticipating the optimal surgical
therapy.
A second principle in approaching cystic liver disease is meticulous analysis of
radiologic imaging. Often, patients presenting for surgical consultation have had
diagnostic or potentially therapeutic procedures previously performed. These not
only include interventional radiologic procedures such as biopsy, needle aspiration,
and sclerotherapy but previous surgical fenestration. Complications such as bleeding or infection from these procedures can signifi cantly alter subsequent imaging
and the occurrence of a complication may not have been clinically recognized. In
situations where any previous procedure has been performed upon a cyst, every
effort should be made to obtain as much possible imaging, particularly crosssectional imaging, that was performed prior to the intervention. If surgery is being
entertained, recent cross sectional imaging ( computed tomography or magnetic
resonance imaging ) will facilitate accurate cyst classifi cation and symptom correlation while reducing the chance of an unanticipated change in surgical plan during
surgery.
Cross sectional imaging analysis focuses upon four specifi c areas: number of
cysts, cyst content, cyst wall architecture, and cyst location. Cysts may be single or
multiple with a homogenous or heterogenous cyst content. The cyst wall architecture may be uniform in thickness or irregular in thickness with projections of
the cyst wall into the lumen or septations. Lastly, does the cyst location support the
patient’s symptoms? Appreciation of multiple closely approximated cysts, heterogeneous cyst content without prior intervention, or any cyst wall architecture that is
not completely uniform are indications for further investigation utilizing intraoperative ultrasound and a surgical approach that requires more than simple
fenestration.
Correlation of cyst location to the patient’s symptoms is particularly important in
the management of congenital cysts. Common presenting symptoms include
abdominal pain , epigastric bloating, early satiety, and dyspepsia [ 2 ]. Large size
(>6 cm), pericapsular or ventral location, and heterogenous content suggesting
previous hemorrhage are typically associated with abdominal pain while epigastric
bloating, early satiety, and dyspepsia are associated with predominantly left lobe,
dorsally located lesions may be symptomatic at a smaller size. Biliary disease,
gastro- esophageal refl ux disease, and other common indications of abdominal
pain should be excluded prior to offering surgery for abdominal pain secondary to
congenital cysts [
2 ].
J.F. Renz

57
Congenital Cysts
Congenital cysts include simple cysts and APLD. Simple cysts are single or multiply scattered, uniform, thin-walled masses with a homogenous, low-viscosity cyst
content. Histologically, the cyst lining is simple cuboidal or columnar epithelium
that produces a serous fl uid. Large cysts are more frequent in women with a female
to male ratio of 4:1 and are uncommon under the age of 40 years. The average
reported size of simple cysts is 3 cm and most are asymptomatic. Simple cysts on
occasion may rupture into the abdominal cavity causing transient peritoneal
discomfort but hemorrhagic rupture is exceedingly rare [ 2 , 3 ].
Simple cysts are ideally approached laparoscopically. The cyst should be carefully examined utilizing intra-operative ultrasound to confi rm a uniform thin lining
with no papillary projections into the cyst lumen or hepatic parenchyma. The cyst
wall typically demonstrates sharp sonographic echo demarcation secondary to the
luminal fl uid interface and compressed hepatic parenchyma [ 4 ]. Simple cyst fl uid is
clear and serous; however, a previous hemorrhage may produce a heterogeneous
mix. In either case, the cyst should be aspirated and a generous excisional biopsy
obtained for histologic evaluation. If a cystadenoma is excluded, the fenestration
may proceed to wide excision of the cyst wall. Intra-operative ultrasound can be
intermittently utilized to maximize wall excision without encountering major vascular structures. Argon beam coagulation of the remnant epithelial surface can be
employed to destroy remaining biliary epithelia and recruit an infl ammatory
response but is not mandatory. When operating for a presumed simple cyst, if a
cystadenoma cannot be excluded or the cyst content is overtly bilious, fenestration
should be abandoned for hepatic resection . If there is a potential cystadenoma, the
resection should include at least a 0.5 cm margin with pathologic confi rmation. In
the scenario of overtly bilious cyst fl uid, the resection is indicated to completely
remove the cyst lining so as to expose biliary radicle(s) for repair.
Percutaneous therapies for the management of simple cysts including aspiration
and sclerotherapy are available. Aspiration as a diagnostic maneuver to assess
symptom alleviation is potentially valuable but should not be considered defi nitive
therapy due to a high recurrence rate [ 5 ]. Notably, aspiration will change the radio-
logic appearance of the cyst. Sclerotherapy may be applied in patients who are poor
surgical candidates but its effi cacy is lower than surgical fenestration [ 6 ].
APLD is most often identifi ed in the presence of polycystic kidney disease and
results from a mutation in the PKD-1 or PKD-2 gene. A rare mutant of the protein
kinase C gene, 80 K-H, can manifest as isolated APLD. Cysts appear similar to
simple cysts except they are far more numerous, generally smaller in size, bilobar in
distribution, and are associated with numerous microcysts in their vicinity. A female
predominance is observed with pregnancy and hormonal therapy implicated in
APLD progression. Renal failure also correlates with APLD progression. APLD is
associated with cerebral artery aneurysm, valvular heart disease, inguinal hernia,
and diverticulosis [ 2 , 3 ].
5 Cystic Diseases of the Liver

58
Symptoms may result from infection, traumatic rupture, intracystic hemorrhage,
Budd-Chiari syndrome, dyspnea, or extrinsic compression of the biliary or digestive
tracts [ 3 ]. Excluding infection, the occurrence of symptoms should be interpreted
as the result of excessive abdominal volume and therapeutic options designed to
signifi cantly reduce volume rather than attention to an isolated cyst(s). Currently,
there are no medical therapies to reduce disease burden or prevent progression [ 2 ].
Surgical therapy designed to substantially reduce abdominal volume offers the
greatest promise for durable benefi t. To this end, substantial knowledge in heptobiliary surgery is required to tailor procedures according to symptoms, cyst distribution, parenchymal preservation, biliary and vascular anatomy. Fenestration or
dominant cyst wall excision is unlikely to yield long-term benefi t. Instead, surgical
resection , preferably laparoscopically, should be optimized to remove the highest
concentration of cysts at the initial operation [ 7 ]. This yields the greatest chance of
durable relief while preserving hepatic function as subsequent attempts at extensive
resections following previous surgical procedures become signifi cantly more diffi cult
and risk parenchymal ischemia. For extensive disease, APLD progression mandates
consideration of liver transplant ation [ 7 ].
While not a true cystic disease, Caroli’s disease does deserve mention as it may
enter the differential diagnosis of a patient presenting with presumed intra-hepatic
cysts. Caroli’s disease is an autosomal recessive congenital malformation with a
female predominance that results from incomplete gestational biliary duct formation. The biliary dilations are not true cysts as each communicates with the biliary
system. Hence, a magnetic resonance cholangiopancreatography will demonstrate
segmental dilatations in one or both hepatic lobes that often contain choledocholiths
[ 2 ]. The most common presentation of Caroli’s disease is cholangitis secondary to
impaired biliary excretion. Caroli’s disease may coexist with congenital hepatic
fi brosis and predisposes to cholangiocarcinoma. When unilobar, more commonly
the left hepatic lobe, surgical resection to include the extra-hepatic biliary tree with
a Roux-en-Y hepaticojejunostomy is preferred. Extensive bilobar disease is a much
more diffi cult condition that mandates ursodeoxycholic acid, surveillance imaging
for cholangiocarcinoma, judicious instrumentation of the biliary tree when absolutely necessary and potential consideration of liver transplant ation [ 2 ].
Neoplastic Cysts
Neoplastic cysts may be primary or metastatic. Primary cystadenocarcinoma of the
liver is uncommon as is its precursor lesion a cystadenoma . Together, they comprise
<1 % of intra-hepatic cystic lesions observed on cross-sectional imaging [ 2 , 8 ].
Metastatic cystic lesions, most commonly from the pancreas or ovary are equally
uncommon; however, both primary and metastatic cystic lesions carry a poor prognosis mandating precise surgical management from the onset to optimize outcome.
Essential to properly managing these lesions is maintaining a high index of suspicion. This is best achieved from the very fi rst examination of cross sectional
J.F. Renz

59
imaging. As previously stated, every effort should be made to observe imaging that
does not refl ect interventions performed upon the cyst. The observation of heterogeneous or mucinous cyst content, septations, papillary projections, irregular wall
thickness or the presence of a mass associated with the cyst is not consistent with
congenital cystic disease. If any of the above are observed, serologic studies to
exclude hydatid should be performed before proceeding to the operating room for
excision of a presumed neoplastic cyst. While carbohydrate antigen 19-9 and
carcinoembryonic antigen levels may be elevated in neoplastic cystic fl uid, these
fi ndings are not diagnostic and attempts to obtain diagnostic cyst fl uid sampling
pre-operatively are not encouraged [ 9 ].
Surgical planning for a presumed neoplastic cyst involves formal hepatic resection to obtain an appropriate surgical margin. If a neoplastic cyst is entertained after
initiating a fenestration procedure, conversion from a laparoscopic to an open procedure may afford improved source control and limit potential tumor distribution
within the abdomen. Whenever one is contemplating reoperation for a recurrent
cyst, particularly if the patient derived their initial care from another provider,
caution in reviewing the surgical procedure and pathology is prudent as is the
performance of a formal hepatic resection .
Traumatic Cysts
The incidence of traumatic cysts within the liver is increasing secondary to the
widespread applicability of percutaneous diagnostic and therapeutic interventions.
Traumatic cysts are a misnomer as they are technically pseudocyst cavities created
secondary to hepatic injury without an epithelial lining. These cavities can be the
result of a subcapsular hematoma, an intra-parenchymal hematoma, or coagulative
necrosis following a parenchymal ablative procedure. Clinically, these patients
present with constitutional signs of sepsis following bacterial superinfection of the
pseudocyst. Initial treatment with broad-spectrum antibiotics and percutaneous
drainage is often successful with surgical debridement and drainage ( laparoscopic
or open ) reserved for unique circumstances [ 2 , 10 ].
Infectious Cysts
Infectious cysts include pyogenic liver abscess , hydatid disease, fungal, and amoebic abscesses as well as extra-hepatic cysts secondary to retained gallstones from a
previous cholecystectomy [ 10 ]. Irrespective of the etiologic agent, the approach to
infectious cysts uniformly involves diagnosis , systemic treatment, cyst evacuation,
and prevention of re-infection. Appropriate history and physical examination, in
addition to serologic assay, are central to the early diagnosis of hydatid disease and
amebiasis. An infectious etiology should also be appropriately excluded in the
5 Cystic Diseases of the Liver

60
pre-operative evaluation of a neoplastic cyst. Following diagnosis, systemic treatment is initiated prior to evacuation of the cyst. Traditional operative therapy for
infectious cysts is rapidly being replaced by percutaneous drainage with surgery
reserved for larger cysts (>5 cm in diameter) or percutaneous treatment failures
[ 11 ]. Following drainage, treatment is continued to prevent superinfection while the
liver remodels.
Pyogenic liver abscess (PLA) has historically resulted from portal venous seeding of bacteria from appendicitis or diverticulitis. In immunocompromised patients,
Candida should be a consideration; however, improved medical therapy has signifi -
cantly lowered the incidence of PLA from these etiologies. Instead, PLA is now the
most commonly the result of biliary tract disease or hepatic parenchymal ablation
[ 2 ]. Hepatic parenchymal ablation with superinfection has been previously described
but biliary tract manipulation, either instrumentation ( ERCP ) or stenting, along with
obstruction from a benign or malignant stricture can incite a PLA [ 2 , 10 ].
Attention to the patient’s medical history in approaching a PLA guides therapy.
In the setting of a PLA secondary to bacterial/fungal seeding, the routine algorithm
advocated above with percutaneous aspiration /drainage is recommended. The decision to leave a drain should be tailored to the situation as repetitive aspiration has
been demonstrated to be equivalent to drainage in smaller (<5 cm diameter) PLA
[ 12 ]. When a PLA from a biliary source is suspected, the treatment should be surgi-
cal, typically a hepatic resection , and directed at the underlying biliary etiology.
Hydatid disease is caused by Echinococcus granulosus or Echinococcus
multilocularis where humans are an intermediate host. Endemic areas include South
America, Middle East, Far East, East Africa, Australia and the Mediterranean
countries where sheep are plentiful. The most common presentation is persistent
right upper quadrant pain secondary to cyst expansion and hepatic parenchymal
compression; however, other serious complications from erosion of hydatid cysts
into biliary and vascular structures have been reported. Cross-sectional imaging and
an eosinophilia can be highly sensitive in conjunction with an appropriate history
but the diagnosis is confi rmed serologically. Surgical management has dramatically
changed from traditional open hepatic resection to percutaneous drainage with
laparoscopy as indicated according to the above infectious cyst protocol [ 2 , 13 , 14 ].
Amebic hepatic abscess secondary to Entamoeba histolytica should be consid-
ered in toxic patients a recent history of visiting tropical climates. The patients
classically present with acute abdominal pain and fever. Cross sectional imaging
demonstrates a single large loculated abscess with a heterogeneous content. The
widespread parenchymal necrosis from the protozoan produces the “anchovy sauce”
appearance of the cystic fl uid. Diagnosis is by serology but, unlike hydatid disease,
these patients do not exhibit eosinophilia. Treatment is as outlines for infectious
cysts utilizing metronidazole, emetine hydrochloride, chloroquine phosphate, or
diloxanide furoate. One unique consideration in amebic abscess is their proclivity to
rupture. When located near the hepatic capsule, early aspiration and drainage is
indicated [ 2 ].
J.F. Renz

61
Summary
Cystic diseases of the liver are common and multifactorial in origin. A standardized
approach to an hepatic cyst, as outlined above, begins with a meticulous history and
physical examination to broadly hypothesize the cyst etiology as congenital, neoplastic, traumatic, or infectious. Detailed radiologic analysis can then be incorporated evaluating the number, location, cyst content, cyst content heterogeneity, and
wall characteristics to refi ne the hypothesis. Serologic studies add further data for
differentiating complex infectious from neoplastic cysts. For infectious cysts, percutaneous drainage is becoming the standard while laparoscopy is the preferred
method for all other cysts requiring surgery .
References
1. Carrim Z, Murchison J. The prevalence of simple renal and hepatic cysts detected by spiral
computed tomography. Clin Radiol. 2003;58:626–9.
2. Reid-Lombardo K, Khan S, Sclabas G. Hepatic cysts and liver abscess. Surg Clin N Am.
2010;90:679–97.
3. Abu-Wasel B, Walsh C, Keough V, Molinari M. Athophysiology, epidemiology, classifi cation,
and treatment options for polycystic liver diseases. World J Gastroenterol. 2013;19:5775–86.
4. Charlesworth P, Ade-Ajayi N, Davenport M. Natural history and long-term follow-up of
antenatally detected liver cysts. J Pediatr Surg. 2007;42:494–9.
5. Saini S, Mueller P, Ferrucci Jr J, Simeone J, Wittenberg J, Butch R. Percutaneous aspiration of
hepatic cysts does not provide defi nitive therapy. Am J Roentgenol. 1983;141:559–60.
6. Erdogan D, van Delden O, Rauws E, et al. Results of percutaneous sclerotherapy and surgical
treatment in patients with symptomatic simple liver cysts and polycystic liver disease. World
J Gastroenterol. 2007;13:3095–100.
7. Schnelldorfer T, Torres V, Zakaria S, Rosen C, Nagorney D. Polycystic liver disease: a critical
appraisal of hepatic resection, fenestration, and liver transplantation. Ann Surg. 2009;250:112–8.
8. Williams D, Vitellas K, Sheafor D. Biliary cystadenocarcinoma: seven year follow-up and the
role of MRI and MRCP. Magn Reson Imaging. 2001;19:1203–8.
9. Koffron A, Rao S, Ferrario M, Abecassis M. Intrahepatic biliary cystadenoma: role of cyst
fl uid analysis and surgical management in the laparoscopic era. Surgery. 2004;136:926–36.
10. Lardiere-Deguelte S, Ragot E, Amroun K, et al. Hepatic abscess: diagnosis and management.
J Visc Surg. 2015;466:1–13.
11. Pearce N, Knight R, Irving H, et al. Non-operative management of pyogenic liver abscess.
HPB. 2003;5:91–5.
12. Yu S, Ho S, Lau W, et al. Treatment of pyogenic liver abscess: prospective randomized com-
parison of catheter drainage and needle aspiration. Hepatology. 2004;39:932–8.
13. Li H, Shao Y, Aji T, et al. Laparoscopic approach for total cystectomy in treating hepatic cystic
echinococcus. Parasite. 2014;21:160–5.
14. Tuxun Y, Zhang J-H, Zhao J-M, Tai Q-W, Abudurexti M. World review of laparoscopic treat-
ment of liver cystic echinococcus – 914 patients. Int J Inf Dis. 2014;24:43–50.
5 Cystic Diseases of the Liver

63© Springer International Publishing Switzerland 2016
J.M. Millis, J.B. Matthews (eds.), Diffi cult Decisions in Hepatobiliary
and Pancreatic Surgery, Diffi cult Decisions in Surgery: An Evidence-Based
Approach, DOI 10.1007/978-3-319-27365-5_6
Chapter 6
When Should You Operate on Major
Hepatic Trauma?
Cory Evans and Martin A. Croce
Abstract Hepatic trauma causes a signifi cant amount of morbidity and mortality.
The decision to on whether or not to operate is a key step in managing this problem.
Operative management carries with it a higher rate of morbidity and mortality than
non-operative management. However, clear indications do exist when an operation
is needed. These include hemodynamic instability, continued bleeding, peritonitis,
and other abdominal injuries requiring operation. Operative management involves a
graded response to the injury. Selected angioembolization can be a useful adjunct to
both operative and non-operative approach to hepatic trauma.
Keywords Hepatic trauma • Operative management • Non-operative management
• Angioembolization
Introduction
Hepatic trauma is associated with a signifi cant amount of morbidity and mortality .
It is a complex and challenging problem to manage. Hemodynamically unstable
patients with a blunt mechanism of injury to the liver should undergo operative
management [ 1 ]. Similarly, patients with penetrating hepatic injuries mostly need
operative management to search for associated intra-abdominal injury [ 2 ]. Non-
operative management (NOM) of hemodynamically stable patients with blunt liver
trauma has become the standard of care. This is a change in philosophy of management of these injuries began to evolve in the early 1990s. Spurred by case reports
and results from the pediatric literature, several studies in this period showed a high
rate of success of NOM for all American Association for the Surgery of Trauma
(AAST) grades of blunt hepatic trauma [ 3 – 5 ]. More recently, several centers have
C. Evans • M. A. Croce (*)
Department of Surgery , University of Tennessee Health Science Center ,
910 Madison Ave, 2nd fl oor , Memphis , TN 38163 , USA
e-mail:
coryevans@gmail.com; mcroce@uthsc.edu
Соседние файлы в папке Библиотека им академика М.И. Перельмана
